Medicine Information

New Antidepressant Developments and Approvals


New antidepressant development, until fairly recently, was at best a random, and at worst a problematic and frustrating, process. Often, medications that were developed for one thing were discovered quite accidentally to have much more important therapeutic effects for a completely different disorder. It has been well described that some of the original antipsychotics were originally developed to assist in anesthesia, and some of the original new antidepressants were originally intended to be medications for tuberculosis or psychosis. New antidepressant development was done on a "chemical" basis; that is, guesses were made as to compounds that would be safe and effective based on chemical structures of established medications. This was very much a trial-and-error process, since very little was known about how these drugs worked and very little could be measured beyond actually giving them to a patient.

New antidepressant development always has been and always will be a partnership between efficacy (ie, whether the drug is effective) and safety (ie, whether the drug can be tolerated by a patient). There were very few ways of knowing the answers to those two questions about any given compound unless you tried it, a process not without its obvious risks. It should be noted that vagus nerve stimulation for depression clearly meets the two main FDA requirements of safety and efficacy.

Medications to treat depression; mild, severe, bipolar, or treatment-resistant, make the news most frequently, and deservedly so. Their progress and approval can potentially benefit almost 8 million Americans who suffer from some form of depression. Because there seems to be more frequency now of depression that is treatment-resistant, meaning most methods of treatment (medications, psychotherapy, electroconvulsive therapy, or a combination of more than one treatment) have failed for a patient, the approval of new antidepressants from companies like Merck, Lilly, and Pfizer, are more important than ever. This is because a new class of medication for treating depression has not been developed in over a decade.

On July 18th, 2005 the FDA approved the first ever treatment long term treatment option for depression; vagus nerve stimulation. You can learn more about this remarkable treatment at http://www.VagusNerveStimulator.com There is a free electronic newsletter to keep you up-to-date.

Charles Donovan was a patient in the FDA investigational trial of vagus nerve stimulation as a treatment for chronic or recurrent treatment-resistant depression. He was implanted with the vagus nerve stimulator in April of 2001. He chronicles his journey from the grips of depression thanks to vagus nerve stimulation therapy in his book:

Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression

The book was exhibited at the American Psychiatric Association's Annual Meeting in May. It is available on his web site and 24 hours a day/7 days a week through the toll free number 1-888-VAGUS-88. If you use discount code FDAYES(all caps), it will save you 25% off the cost of the book and you will get automatic free shipping via U.S. Postal Priority Mail.

The book is also available through Amazon.com and Barnes & Noble.com. The discount does not apply at these two sites.

He is the founder of the http://www.VagusNerveStimulator.com Web Site


MORE RESOURCES:

Fange added to SIU’s School of Medicine
Hannibal.net, MO - 16 hours ago
Dr. Timothy James Von Fange has joined the faculty at Southern Illinois University School of Medicine in Quincy as an assistant professor of family and ...
Blessing offering EEGs Hannibal.net
all 2 news articles


Readers want no part of two-tier medicine
Toronto Star,  Canada - 12 hours ago
Dr. Robert Ouellet advances the idea that Canada can develop a European-style health-care system with a public-private blend. This fallacy is promoted by ...
Computerized Reminder System Drove Up Colon Cancer Screening Rates Medical News Today (press release)
all 3 news articles


Ex-NJ politician headed to trial on fraud charges
The Associated Press - 2 hours ago
Wayne R. Bryant is also accused of steering state money to one of his employers, the University of Medicine and Dentistry of New Jersey. ...


Bostwick Therapeutics Announces Initiation of Novel Phase I/II ...
MarketWatch - Sep 5, 2008
... of each patient's own immature dendritic cells obtained from blood-borne precursors and introduced back to the individual ("personalized medicine"). ...


Prof. Mark Kelley '79 Receives New Appointment at IU School of ...
DePauw University, IN - Sep 5, 2008
... of DePauw University, has been appointed Betty and Earl Herr Professor of Pediatric Oncology Research at the Indiana University School of Medicine. ...


Regenerative Medicine International (RMI) Signs AdiStem ...
PR-USA.net (press release), Bulgaria - 16 hours ago
AdiStem, a leading provider of autologous, adipose-derived adult stem cell products and procedures has appointed Regenerative Medicine International to ...


Amarillo Medicine Man On The Move
KFDA, TX - 19 hours ago
Slow moving insurance, Medicare and online pharmacies are just a few of the reasons Amarillo's medicine man closed his doors on Friday. ...


LMHP announces six new staff members
The Newark Advocate, OH - 10 hours ago
Klima earned his medical degree at Wright State University School of Medicine, Dayton. He completed a pediatric residency at Children's Hospital in Columbus ...


Emergency physician dubbed a 'hero' by doctors association
San Mateo Daily News, CA - 9 hours ago
Dr. Michael Bresler, director of emergency medicine for Mills-Peninsula Health Services, was named a "Hero of Emergency Medicine" by the American College of ...


CBS News

Pollution risk report was flawed, panel says
Detroit Free Press, United States - 14 hours ago
The CDC asked the Institute of Medicine, an independent board, to review the 2007 report. On Friday, an 11-member institute committee said the report was ...
Review panel criticizes Great Lakes health study WTTE
Review panel criticizes Great Lakes health study WREX-TV
Great Lakes pollution can't be tied to health woes, review finds Detroit Free Press
all 341 news articles

Medicine - Google News

home | site map | Dr. Thad Thomas
© 2006